Medical Device Innovation: The OcuCheck
by Leanne Labriola, DO, MBA
Carle Illinois College of Medicine - Innovation Grand Rounds
Friday, July 10, 2020
noon – 1:00 p.m. Hear from Dr. Labriola
1:00 – 1:30 p.m. Reflection & Dialogue
Zoom Call-in: go.illinois.edu/innovationgrandrounds
Meeting ID: 966 9995 0259 Password: 014744
Abstract:
Medical device innovation involved three phases: Identify, Invent and Implement. This discussion with review the aspects of those phases by exploring concepts involved with identifying a clinical need, creating a disruptive technology and establishing a viable business. The presentation will highlight the path of invention of the OcuCheck as a practical example of this process.
Dr. Labriola is a board-certified ophthalmologist at Carle Foundation Hospital in Urbana, Illinois with an appointment at the University of Illinois, Urbana-Champaign. She graduated from Duke University with a bachelor of science in Biology. She attended medical school at the Philadelphia College of Osteopathic Medicine where she served as the President of the Student Government Association during her third year. She completed ophthalmology residency at the University of Pittsburgh and then went on for fellowship training in medical retina at the University of Southern California. She has experience in clinical and bench research. Previously, she worked at the University of Pittsburgh Medical Center as an ophthalmologist. Since joining Carle in 2013, she has started the ophthalmology clinical research program here which has participated in over 15 sponsored national clinical trials that offer new treatments to patients with macular degeneration, diabetes or retina vein occlusions. Her research focus is on improved methods for ophthalmic diagnosis which has resulted in many publications in peer-reviewed journals. She has received funding for this work through the National Science Foundation and private grants. In addition, Dr. Labriola received her MBA degree in 2018 from Haub Business School in Philadelphia, PA. She is co-founder and Chief Executive Officer of a start-up biotech company called, InnSight Technology, Inc., and has recently started a new company called Visionaire Products, Inc. Both companies are focused on the development of novel diagnostic devices in ophthalmology.
